Inventor · disambiguated record
Danica Cartwright
Also filed as: CARTWRIGHT DANICA
0 granted patents·5 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
5 records- 0178US2024082275A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0271US2022249524A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0369US2021401860A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0466US2021186994A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 0555US2018256610A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Danica Cartwright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →